glp-1 agonist hair loss after starting a medication left this patient feeling discouraged, but these early results show what's possible with the right support. This before and after reflects improvement after the first A clinician's perspective π GLP-1
Description
This is a preview of subscription content, access via your institution Access options Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription 27,99 / 30 days cancel any time Subscribe to this journal Receive 12 digital issues and online access to articles 135,68 per year only 11,31 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF
The Federal Register docket number for this proposal is 2026-08552

Is constipation one of the common side effects

[5] Additionally, GLP-1 receptor agonists carry risks of gallbladder disease (cholelithiasis, cholecystitis) and pancreatitis that may present with abdominal pain and other gastrointestinal symptoms

Any changes to diet or medication regimens should be discussed with a GP, diabetes specialist nurse, or registered dietitian
Anti-IAPP monoclonal antibody improves clinical symptoms in a mouse model of type 2 diabetes
